E-MAIL: [email protected]
FDA grants accelerated approval to datopotamab deruxtecan-dlnk for EGFR-mutated non-small cell lung cancer
232025.06
FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma
202025.06
To ensure these pens meet strict regulatory standards and perform safely for patients, manufacturers need to conduct thorough tes...
182025.06
Xinfuda welcomes GMP upgrade of pharmaceutical packaging materials
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
Reserved Powered by
MAKE AN ENQUIRY
